Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients

8 Nov 2012

Abstract excerpt

BACKGROUND: The enzymes encoded by the GALNT [UDP-N-acetyl-α-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GALNAC-T)] gene family catalyze the first step of O-glycosylation. Little is known about the link between expression of the genes encoding GALNAC-T enzymes and tumor progression in neuroblastoma, a pediatric cancer that can be classified as either low or high risk. We assessed the expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Neuroblastoma Research and Treatments
Share to Proteoglycans and glycosaminoglycans research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23136245
DOI: 10.1373/clinchem.2012.192328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma PatientsPMID 23136245Read ↗

ppGalNAc-T13: A New Molecular Marker of Bone Marrow Involvement in NeuroblastomaSemantic proximity Read ↗

Identification of GALNT14 as a novel neuroblastoma predisposition gene.Semantic proximity Read ↗

B4GALNT3 Expression Predicts a Favorable Prognosis and Suppresses Cell Migration and Invasion via β1 Integrin Signaling in NeuroblastomaSemantic proximity Read ↗

GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.Semantic proximity Read ↗

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastomaSemantic proximity Read ↗

Neural crest-related NXPH1/α-NRXN signaling opposes neuroblastoma malignancy by inhibiting metastasisSemantic proximity Read ↗

Identification of Key Genes Associated with Risk and Prognosis of NeuroblastomaSemantic proximity Read ↗

A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma PatientsSemantic proximity Read ↗

Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk NeuroblastomaSemantic proximity Read ↗

Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified NeuroblastomaSemantic proximity Read ↗

Increased efficacy of histone methyltransferase G9a inhibitors against MYCN-amplified NeuroblastomaSemantic proximity Read ↗

Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting inMYCN-amplified neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.